药物防治激素性股骨头坏死的研究进展
摘要点击次数: 1687   全文下载次数: 1163   投稿时间:2006-06-13    
作者Author单位AddressE-Mail
李卫哲 LI Wei-zhe 天津医院,天津300211 The Hospital of Tianjin,Tianjin 300211,China lize163111@163.com 
金硕 JIN Shuo 天津医院,天津300211 The Hospital of Tianjin,Tianjin 300211,China  
杨明富 YANG Ming-fu 天津医院,天津300211 The Hospital of Tianjin,Tianjin 300211,China  
贾军 JIA Jun 天津医院,天津300211 The Hospital of Tianjin,Tianjin 300211,China  
期刊信息:《中国骨伤》2007年,第20卷,第1期,第62-63页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
基金项目:
中文摘要:随着激素性股骨头坏死发病机制研究的深入,使药物防治激素性股骨头坏死成为可能。本文回顾了近年来一些国内外学者根据其发病机制进行的药物预防激素性股骨头坏死的研究,提出降脂、抗凝药联用不能完全预防激素性股骨头坏死的发生,激素性股骨头坏死是以脂肪代谢紊乱和血管内凝血为主要发病机制,其他一些病理机制共同作用的结果。
【关键词】抗凝药  降脂药  股骨头坏死
 
Progress of the prevention and cure of steroidinduced necrosis of the femoral head with medicine
ABSTRACT  It is possible that the medicine can prevent or cure steroid-induced necrosis of the femoral head,with the deepening of research of the pathogenesis of steroid-induced necrosis of femoral head.This article reviewed some studies about preventive effect of medicine on steroid-induced necrosis of femoral head during the past few years.Antilipemic and anticoagulant medicine can not prevent the stetoid-induced necrosis of femoral head completely,the main pathogenesis of stetoid-induced necrosis of femoral head is fat metabolic disorder and intravascular coagulation,with other factors cooperating together.
KEY WORDS  Anticoagulants  Antilipemic  Necrosis of femoral head
 
引用本文,请按以下格式著录参考文献:
中文格式:李卫哲,金硕,杨明富,贾军.药物防治激素性股骨头坏死的研究进展[J].中国骨伤,2007,20(1):62~63
英文格式:LI Wei-zhe,JIN Shuo,YANG Ming-fu,JIA Jun.Progress of the prevention and cure of steroidinduced necrosis of the femoral head with medicine[J].zhongguo gu shang / China J Orthop Trauma ,2007,20(1):62~63
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号